Hong Kong Says Experts to Discuss Sinovac Vaccine

The transcript discusses the approval and distribution of vaccines in Hong Kong, including BioNTech, Sinovac, and AstraZeneca. It addresses challenges in the vaccine rollout, such as international competition and data submission delays. The conversation also covers social restrictions, testing strategies, and the possibility of residents choosing their vaccine. Plans for reopening the border with China and the continuation of lockdown strategies are also discussed, with a focus on improving the epidemic situation and returning to normalcy.

How does the government plan to manage social restrictions?

What is the expected timeline for the Astra Zeneca vaccine delivery?

What factors will influence the reopening of the border with China?

What measures are being taken to ensure the safety and efficacy of the vaccines?